Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E M Griffiths

Showing results (191-200 of 337) with videos related to

Pageof 34
Sort By:
Frontiers in Aging|August 24, 2023
Behaviour and sun exposure in holidaymakers alters skin microbiota composition and diversityThomas Willmott, Paul M Campbell, Christopher E M Griffiths, et al.
Journal of the American Academy of Dermatology|December 18, 2007
Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 yearPhoebe Rich, Christopher E M Griffiths, Kristian Reich, et al.
Immunity, Inflammation and Disease|June 4, 2026
Dandruff Is a Low-Grade Inflammatory Condition Featuring Hyperproliferative Keratinocytes, Interleukin-17-Producing T Cells, and N-Acyl EthanolaminesAlexandra C Kendall, Karishma Mohamed, Holly Linley, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Pilot study assessing pathophysiology and healing of digital ulcers in patients with systemic sclerosis using laser Doppler imaging and thermographyAndrea K Murray, Tonia L Moore, Elizabeth Wragg, et al.
The British Journal of Dermatology|January 22, 2022
How do dermatologists' personal models inform a patient-centred approach to management: a qualitative study using the example of prescribing a new treatment (Apremilast)Rachael M Hewitt, Chris Bundy, Antonia-Luise Newi, et al.
Arthritis and Rheumatism|October 29, 2005
Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritisPauline Ho, Ian N Bruce, Alan Silman, et al.
Journal of the American Academy of Dermatology|June 1, 2020
Bimekizumab for patients with moderate to severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled, phase 2b extension studyAndrew Blauvelt, Kim A Papp, Joseph F Merola, et al.
JAMA Dermatology|June 7, 2023
Fertility Trends and Adverse Pregnancy Outcomes in Female Patients With Psoriasis in the UKTeng-Chou Chen, Ireny Y K Iskandar, Rosa Parisi, et al.
Age (Dordrecht, Netherlands)|April 16, 2015
Disentangling the effects of circulating IGF-1, glucose, and cortisol on features of perceived ageKelly van Drielen, David A Gunn, Raymond Noordam, et al.
The British Journal of Dermatology|April 4, 2023
Uptake of tumour necrosis factor-alpha inhibitor biosimilars for psoriasis: a drug utilization study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)Duc Binh Phan, Anthony P Bewley, Catherine H Smith, et al.
Pageof 34

Showing results (191-200 of 337) with videos related to

Sort By:
Pageof 34
Frontiers in Aging|August 24, 2023
Behaviour and sun exposure in holidaymakers alters skin microbiota composition and diversityThomas Willmott, Paul M Campbell, Christopher E M Griffiths, et al.
Journal of the American Academy of Dermatology|December 18, 2007
Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 yearPhoebe Rich, Christopher E M Griffiths, Kristian Reich, et al.
Immunity, Inflammation and Disease|June 4, 2026
Dandruff Is a Low-Grade Inflammatory Condition Featuring Hyperproliferative Keratinocytes, Interleukin-17-Producing T Cells, and N-Acyl EthanolaminesAlexandra C Kendall, Karishma Mohamed, Holly Linley, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Pilot study assessing pathophysiology and healing of digital ulcers in patients with systemic sclerosis using laser Doppler imaging and thermographyAndrea K Murray, Tonia L Moore, Elizabeth Wragg, et al.
The British Journal of Dermatology|January 22, 2022
How do dermatologists' personal models inform a patient-centred approach to management: a qualitative study using the example of prescribing a new treatment (Apremilast)Rachael M Hewitt, Chris Bundy, Antonia-Luise Newi, et al.
Arthritis and Rheumatism|October 29, 2005
Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritisPauline Ho, Ian N Bruce, Alan Silman, et al.
Journal of the American Academy of Dermatology|June 1, 2020
Bimekizumab for patients with moderate to severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled, phase 2b extension studyAndrew Blauvelt, Kim A Papp, Joseph F Merola, et al.
JAMA Dermatology|June 7, 2023
Fertility Trends and Adverse Pregnancy Outcomes in Female Patients With Psoriasis in the UKTeng-Chou Chen, Ireny Y K Iskandar, Rosa Parisi, et al.
Age (Dordrecht, Netherlands)|April 16, 2015
Disentangling the effects of circulating IGF-1, glucose, and cortisol on features of perceived ageKelly van Drielen, David A Gunn, Raymond Noordam, et al.
The British Journal of Dermatology|April 4, 2023
Uptake of tumour necrosis factor-alpha inhibitor biosimilars for psoriasis: a drug utilization study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)Duc Binh Phan, Anthony P Bewley, Catherine H Smith, et al.
Pageof 34